Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China

Fig. 4

Validation of DEGs by RT-qPCR and immunohistochemistry. A–C The qRT-PCR results showed that the mRNA expression of CD19, CD22, and CD72 were relatively lower in PBL than in DLBCL. D–F The RT-qPCR results showed that the expression of SDC1, CHRM3, and HTR2C were relatively higher in PBL were relatively lower in PBL than in DLBCL. G, H The expression of CD19 and CD22 detected by IHC. Magnification, x200

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us